161 related articles for article (PubMed ID: 38133686)
1. Letter to the editor for the article "Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis".
Yang H; Li M; Zhao Y; Yang H
World J Urol; 2023 Dec; 42(1):4. PubMed ID: 38133686
[No Abstract] [Full Text] [Related]
2. Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis.
Sari Motlagh R; Abufaraj M; Karakiewicz PI; Rajwa P; Mori K; Mun DH; Shariat SF
World J Urol; 2022 Apr; 40(4):907-914. PubMed ID: 34477955
[TBL] [Abstract][Full Text] [Related]
3. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.
Klein EA; Li J; Milinovich A; Schold JD; Sharifi N; Kattan MW; Jehi L
J Urol; 2021 Feb; 205(2):441-443. PubMed ID: 32897764
[TBL] [Abstract][Full Text] [Related]
4. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. Letter.
MacDonald S; Matos de Oliveira A; Wambier CG
J Urol; 2021 Sep; 206(3):784-785. PubMed ID: 33998834
[No Abstract] [Full Text] [Related]
5. Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry.
Kwon DH; Vashisht R; Borno HT; Aggarwal RR; Small EJ; Butte AJ; Huang FW
Ann Oncol; 2021 May; 32(5):678-679. PubMed ID: 33571636
[No Abstract] [Full Text] [Related]
6. Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection.
Davidsson S; Messing Eriksson A; Udumyan R; Swanholm P; Lewin Lundh M; Widing C; Lindlöf C; Fridfeldt J; Andersson SO; Fall K
Prostate; 2023 May; 83(6):555-562. PubMed ID: 36658755
[TBL] [Abstract][Full Text] [Related]
7. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2. Reply.
Klein EA
J Urol; 2021 Sep; 206(3):785. PubMed ID: 33998833
[No Abstract] [Full Text] [Related]
8. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Kim DK; Park JJ; Yang WJ; Doo SW; Kim JH
J Korean Med Sci; 2022 Aug; 37(31):e237. PubMed ID: 35942555
[TBL] [Abstract][Full Text] [Related]
10. Effects of Androgen Deprivation Therapy on COVID-19 in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis.
Karimi A; Nowroozi A; Alilou S; Amini E
Urol J; 2021 Jul; 18(6):577-584. PubMed ID: 34302737
[TBL] [Abstract][Full Text] [Related]
11. [Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].
Manolache NG; Mjaess G; Diamand R; Albisinni S; Roumeguère T
Prog Urol; 2022 Dec; 32(16):1421-1430. PubMed ID: 36163317
[TBL] [Abstract][Full Text] [Related]
12. Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (n = 4532).
Brookman-May SD; May M
Eur Urol; 2020 Dec; 78(6):930-931. PubMed ID: 32591101
[No Abstract] [Full Text] [Related]
13. Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer.
Huang YB; Li WL; Sun M; Duan X; Wang YT; Zhang LX; Xin ZH; Yun ZF; Fan B; Li XC
Asian J Androl; 2023; 25(3):366-374. PubMed ID: 35915542
[TBL] [Abstract][Full Text] [Related]
14. Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
Jiménez-Alcaide E; García-Fuentes C; Hernández V; De la Peña E; Pérez-Fernández E; Castro A; Caballero-Perea B; Guijarro A; Llorente C
Prostate; 2021 Dec; 81(16):1349-1354. PubMed ID: 34517429
[TBL] [Abstract][Full Text] [Related]
15. Do Anti-androgens Have Potential as Therapeutics for COVID-19?
Mauvais-Jarvis F
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 34089595
[TBL] [Abstract][Full Text] [Related]
16. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
Schmidt AL; Tucker MD; Bakouny Z; Labaki C; Hsu CY; Shyr Y; Armstrong AJ; Beer TM; Bijjula RR; Bilen MA; Connell CF; Dawsey SJ; Faller B; Gao X; Gartrell BA; Gill D; Gulati S; Halabi S; Hwang C; Joshi M; Khaki AR; Menon H; Morris MJ; Puc M; Russell KB; Shah NJ; Sharifi N; Shaya J; Schweizer MT; Steinharter J; Wulff-Burchfield EM; Xu W; Zhu J; Mishra S; Grivas P; Rini BI; Warner JL; Zhang T; Choueiri TK; Gupta S; McKay RR
JAMA Netw Open; 2021 Nov; 4(11):e2134330. PubMed ID: 34767021
[TBL] [Abstract][Full Text] [Related]
17. Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed.
Ianhez M; Ramos PM; Goren A; Miot HA
Dermatol Ther; 2020 Nov; 33(6):e14166. PubMed ID: 32772478
[No Abstract] [Full Text] [Related]
18. Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
Qiao Y; Wotring JW; Zheng Y; Zhang CJ; Zhang Y; Jiang X; Pretto CD; Eyunni S; Parolia A; He T; Cheng C; Cao X; Wang R; Su F; Ellison SJ; Wang Y; Qin J; Yan H; Zhou Q; Ma L; Sexton JZ; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2221809120. PubMed ID: 37459541
[TBL] [Abstract][Full Text] [Related]
19. [Can androgen deprivation therapy play a protective role in SARS-CoV-infections?].
Schlack K; Krabbe LM
Urologe A; 2020 Oct; 59(10):1251-1253. PubMed ID: 32776230
[No Abstract] [Full Text] [Related]
20. Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic.
Dee EC; Mahal BA; Arega MA; D'Amico AV; Mouw KW; Nguyen PL; Muralidhar V
JAMA Oncol; 2020 Oct; 6(10):1630-1632. PubMed ID: 32789489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
